Unique Ingredient Identifier XHX3C3X673 is listed as a ingredient substance
| RN | 102-76-1 |
| EC | 203-051-9 |
| NCIT | C82268 |
| RXCUI | 10756 |
| PUBCHEM | 5541 |
| INN ID | 836 |
| MF | C9H14O6 |
| INCHI KEY | URAYPUMNDPQOKB-UHFFFAOYSA-N |
| SMILES | CC(=O)OCC(COC(C)=O)OC(C)=O |
UNII XHX3C3X673 TRIACETIN is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ENDOCERVICAL | GEL | NA |
| ORAL | CAPSULE | 6.42 MG |
| ORAL | CAPSULE, COATED PELLETS | 1.21 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 5.1 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 46.7 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 2.76 MG |
| ORAL | CONCENTRATE | 50 MG/1ML |
| ORAL | POWDER, FOR ORAL SUSPENSION | 1.02 MG/5ML |
| ORAL | SUSPENSION | 0.32 MG/1ML |
| ORAL | SUSPENSION, EXTENDED RELEASE | 1.18 MG/5ML |
| ORAL | TABLET | 6 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 0.72 MG |
| ORAL | TABLET, CHEWABLE | 1.36 MG |
| ORAL | TABLET, COATED | 1 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 6 MG |
| ORAL | TABLET, DELAYED RELEASE | 1.82 mg |
| ORAL | TABLET, EXTENDED RELEASE | 8 MG |
| ORAL | TABLET, FILM COATED | 15.12 MG |
| ORAL | TABLET, SUSTAINED ACTION | 1.96 MG |
| TRANSDERMAL | PATCH | 22.1 MG |
| TRANSDERMAL | PATCH, CONTROLLED RELEASE | 22.1 MG |